GSK
GSK
GSK
848 hedge funds and large institutions have $14.2B invested in GSK in 2025 Q1 according to their latest regulatory filings, with 89 funds opening new positions, 325 increasing their positions, 276 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more funds holding in top 10
Funds holding in top 10: 12 → 14 (+2)
1% more funds holding
Funds holding: 842 → 848 (+6)
0.62% more ownership
Funds ownership: 8.25% → 8.87% (+0.62%)
Holders
848
Holding in Top 10
14
Calls
$243M
Puts
$146M
Top Buyers
| 1 | +$434M | |
| 2 | +$396M | |
| 3 | +$283M | |
| 4 |
Holocene Advisors
New York
|
+$186M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$103M |
Top Sellers
| 1 | -$195M | |
| 2 | -$84.5M | |
| 3 | -$78M | |
| 4 |
AC
Armistice Capital
New York
|
-$77.5M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$73.2M |